In Phase 1 Clinical Trials

Since 2005, WCCT an Altasciences company, has designed and conducted over 160 First-in-Human studies. Our comprehensive, full service, early development offerings and experience help you develop sound strategies and allow you to minimize the time taken to make critical go/no-go decisions by harmonizing our clinical pharmacology facilities, biomarker capabilities, PK/PD analysis expertise, and program knowledge.

Learn more about WCCT Global, an Altasciences company’s First-in-Human capabilities by downloading our fact sheet.

You may also be interested in the following:

First-In-Human Whitepaper:

7 Items to Consider when Planning First-in-Human Trials

Case Study:

First-in-Human Trial in a Special Population

Start typing and press Enter to search